By
Bill Fisher
| October 21st, 2020
Right now, there is a current study going on using oral spray, called sativex. It is licensed in the United States, United Kingdom and the European Union for multiple sclerosis. The study is looking to repurpose this drug for dementia patients, particularly in aggression and agitation.